Covance looks to cut external lab testing costs by 65% with new offering
CRO Covance has launched an external laboratory management service offering for biopharmaceutical sponsors looking to external lab testing for its clinical trials.
CRO Covance has launched an external laboratory management service offering for biopharmaceutical sponsors looking to external lab testing for its clinical trials.
Merck, Novartis, GlaxoSmithKline, Celgene and industry groups are taking issue with recent FDA draft guidance on how manufacturers can reject or limit agency inspectors.
Cromsource has opened offices in Paris in response to the growth of pharma R&D which is flourishing under French Government incentives, the company says.
Aesica has started expanding capacity at its pre-filled syringe plant in the UK after predicting a surge in demand.